Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (MBL-HCV1)

This study has been terminated.
(The study was terminated due to funding constraints)
Sponsor:
Information provided by (Responsible Party):
MassBiologics
ClinicalTrials.gov Identifier:
NCT01532908
First received: February 10, 2012
Last updated: April 24, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 27, 2015
  Primary Completion Date: August 27, 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 13, 2016